Clinical trial
A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
NCT06336148
Study timeline
Study start (actual)2024-06-05Date precision: day
Registry last updated2025-10-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Solid Tumorunresolved
Interventions
ACTM-838DRUG
Sponsors & collaborators
Actym Therapeutics, Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06336148 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.